カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

細胞単離/細胞分離の世界市場予測（～2028年）：製品別、細胞別、細胞源別、技術別、用途別、エンドユーザー別

◆英語タイトル：Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028

MarketsandMarketsが発行した調査報告書（BT2757-23）◆商品コード：BT2757-23
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2023年5月19日
◆ページ数：309
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

MarketsandMarkets社の本調査レポートでは、世界の細胞単離/細胞分離市場規模が2023年の44億ドルから2028年までに82億ドルに拡大し、予測期間中に年平均13.4%で成長すると予想しています。本書では、細胞単離/細胞分離の世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（消耗品、器具）分析、細胞別（ヒト細胞、動物細胞）分析、細胞源別（骨髄、脂肪組織、臍帯血/胚性幹細胞、その他）分析、技術別（遠心分離、表面マーカー、濾過）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などの内容を掲載しています。また、参入企業情報として、Danaher Corporation（US）、Merck KGaA（Germany）、Thermo Fisher Scientific, Inc.（US）などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の細胞単離/細胞分離市場規模：製品別
- 消耗品の市場規模
- 器具の市場規模
・世界の細胞単離/細胞分離市場規模：細胞別
- ヒト細胞の市場規模
- 動物細胞の市場規模
・世界の細胞単離/細胞分離市場規模：細胞源別
- 骨髄由来細胞の市場規模
- 脂肪組織由来細胞の市場規模
- 臍帯血/胚性幹細胞
- その他細胞源の市場規模
・世界の細胞単離/細胞分離市場規模：技術別
- 遠心分離の市場規模
- 表面マーカー分離の市場規模
- ろ過分離の市場規模
・世界の細胞単離/細胞分離市場規模：地域別
- 北米の細胞単離/細胞分離市場規模
- ヨーロッパの細胞単離/細胞分離市場規模
- アジア太平洋の細胞単離/細胞分離市場規模
- 中南米の細胞単離/細胞分離市場規模
- 中東・アフリカの細胞単離/細胞分離市場規模
・競争状況
・企業情報

“世界の細胞単離市場規模は2023年の44億米ドルから2028年には82億米ドルに達すると予測され、予測期間中のCAGRは13.4%”
細胞ベースの研究に対する資金提供の増加などの要因が、市場の成長を加速させています。慢性疾患や感染症の罹患率は上昇傾向にあり、細胞単離技術を必要とする細胞ベースの治療法を含む新しい治療法の需要を促進しています。マイクロ流体ベースの細胞ソーティング、磁気活性化細胞ソーティング、蛍光活性化細胞ソーティングなどの新しく高度な細胞分離技術の開発が市場の成長を促進しています。政府や民間団体がライフサイエンスやバイオテクノロジー研究に多額の投資を行っていることが、細胞分離製品や技術の需要を促進しています。

“消耗品セグメントは2023-2028年の予測期間中に最も高いCAGRで成長しそうです。”
製品別では、細胞単離市場は消耗品と機器に区分されます。消耗品セグメントは予測期間中に最も高いCAGRで成長すると予測されています。この成長は、細胞ベースの研究における消耗品の需要の増加に起因しています。これはセグメント成長にプラスの影響を与えそうです。消耗品は、手作業による細胞単離手順の必要性を減らすことで時間を節約することができます。これは、臨床現場など時間が重要な用途では特に重要です。さまざまな実験条件や細胞種に対応できるため、研究者はそれぞれのニーズに合わせてプロトコルをカスタマイズすることができます。消耗品は単離プロセス中のコンタミネーション（汚染）のリ スクを減らすことができ、これは単離された細胞の完全性を 維持するために重要です。消耗品は多くの場合、遺伝子発現解析やプロテオミクスなど、さまざまな下流のアプリケーションに適合するように設計されています。

“ヒト細胞セグメントが2023年に圧倒的シェアを占める見込み”
細胞の種類に基づき、市場はヒト細胞と動物細胞に区分されます。ヒト細胞を用いた研究への投資が増加していることから、予測期間中はヒト細胞分野が圧倒的なシェアを占める見込みです。HeLa細胞などのヒト細胞株は数十年にわたって研究に使用されており、医学研究の多くの分野で重要なツールとなっています。確立された細胞株が利用できるようになったことで、研究者はヒト細胞を入手し、研究することが容易になりました。ヒト細胞はヒトの生理学や疾病をより正確に表現するため、研究においてヒト細胞を使用することは、研究室から臨床への知見の提供を促進します。研究におけるヒト細胞の使用は、動物細胞の使用よりも一般に受け入れられやすい。

“骨髄細胞単離セグメントは2023-2028年の予測期間中に最も高いCAGRで成長”
細胞源に基づいて、細胞単離市場は脂肪組織、骨髄、臍帯血/胚性幹細胞、およびその他の細胞源にセグメント化されます。予測期間中、最も高いCAGRで成長すると予測されるのは骨髄セグメントです。骨髄には、造血幹細胞、間葉系幹細胞、免疫細胞など、多様な細胞集団が含まれています。骨髄には、造血幹細胞、間葉系幹細胞、免疫細胞など、多様な細胞が含まれています。これらの細胞は単離され、研究、創薬、細胞を用いた治療など、幅広い用途に使用することができます。骨髄細胞の単離は長年にわたって確立され、標準化されてきたため、研究者は高品質の細胞を容易に得ることができます。

“表面マーカーベースの細胞単離セグメントは、2023-2028年の予測期間中に最も高いCAGRで成長”
技術ベースで、細胞単離市場は遠心分離ベースの細胞単離、表面マーカーベースの細胞単離、ろ過ベースの細胞単離にセグメント化されます。予測期間中、最も高いCAGRで成長すると予測されるのは表面マーカーベースの単離分野です。この成長は、製薬業界におけるこの技術の需要の増加に起因しています。これはセグメント成長を促進する可能性が高いです。

“2022年、生体分子分離セグメントが圧倒的シェアを保持”
細胞単離市場は用途に基づき、生体分子単離、幹細胞研究、がん研究、体外診断、組織再生・再生医療、その他の用途に区分されます。細胞単離市場では生体分子分離分野が圧倒的なシェアを占めています。

“製薬・バイオテクノロジー企業セグメントは2023-2028年の予測期間中に最も高いCAGRで成長”
エンドユーザーに基づき、細胞単離市場は製薬・バイオテクノロジー企業、学術・研究機関、病院・診断研究所、その他のエンドユーザーに区分されます。予測期間中、最も高いCAGRで成長するのは製薬・バイオテクノロジー企業セグメントです。製薬・バイオテクノロジー企業が研究開発活動に注力していることが、市場成長を予測する主な要因の1つです。

“アジア太平洋地域はより速いペースで成長”
細胞単離市場は、北米、欧州、アジア太平洋地域、中南米、中東・アフリカに分けられます。2022年には北米が細胞単離市場で圧倒的なシェアを占めました。同地域の優位性は、同地域における支配的かつ主要な市場プレイヤーの存在、技術の進歩など様々な要因によるものです。アジア太平洋地域は、人口の増加や医療施設のインフラ整備に対する政府の取り組みなど様々な要因により、より速いペースで成長する可能性があります。

本レポートのために実施した一次インタビューは以下のように分類されます：
– 回答者別 供給側80%、需要側20％
– 回答者の役職別（供給側） 管理職 – 35%、CXOおよび取締役 – 20%、経営幹部 – 45％
– 地域別 北米：25％、欧州：30％、アジア太平洋地域：30％、中南米：10％、中東・アフリカ：5％

レポート掲載企業リスト
• Danaher Corporation (US)
• Merck KGaA (Germany)
• Thermo Fisher Scientific, Inc. (US)
• Becton, Dickinson and Company (US)
• Terumo Corporation (Japan)
• Agilent Technologies, Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• Corning Incorporated (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Miltenyi Biotec (Germany)
• STEMCELL Technologies (Canada)
• Alfa Laval (Sweden)
• Sartorius AG (Germany)
• Akadeum Life Sciences (US)
• Bio-Techne (US)
• PerkinElmer Inc. (US)
• Invent Biotechnologies, Inc. (US)
• Takara Bio, Inc. (Japan)
• MiCareo Inc. (US)
• Proteintech Group, Inc. (US)
• QIAGEN (Germany)
• Lonza (Switzerland)
• Promega Corporation (US)
• PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany)
• MagBio Genomics (US)

調査範囲
この調査レポートは細胞単離市場の詳細な状況を掲載しています。製品、細胞タイプ、細胞源、技術、用途、エンドユーザー、地域などの異なるセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの会社概要、最近の動向、主要な市場戦略とともに、詳細な競合分析も掲載しています。

本レポートは、以下のポイントに関する洞察を提供します：
– 細胞単離市場の成長に影響を与える主な促進要因（細胞ベースの研究に対する政府資金の増加、癌や感染症に苦しむ患者の増加、技術の進歩）、阻害要因（胚性幹細胞分離に関する倫理的・安全性の問題、細胞ベースの研究の高コスト）、機会（新興市場における成長機会）、課題（細胞療法開発の障害）分析。
– 製品開発/イノベーション： 新しく発売された製品に関する詳細な洞察、細胞単離市場の技術評価。
– 市場開発： 有利な市場に関する包括的な情報-本レポートは様々な地域の細胞単離市場を分析。
– 市場の多様化： 細胞単離市場における新製品、未開拓の地域、最近の開発、投資に関する詳細な情報。
– 競合評価： 細胞単離市場における主要企業の市場シェア、成長戦略、製品提供に関する詳細な評価。

❖ レポートの目次 ❖

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
1.2.1 INCLUSIONS & EXCLUSIONS 31
1.3 MARKET SCOPE 32
FIGURE 1 CELL ISOLATION MARKET SEGMENTATION 32
1.3.1 YEARS CONSIDERED 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 34
1.7 SUMMARY OF CHANGES 34
1.7.1 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY RESEARCH 37
2.1.2 PRIMARY RESEARCH 37
FIGURE 3 CELL ISOLATION MARKET: PRIMARY RESPONDENTS 38
2.2 MARKET ESTIMATION METHODOLOGY 39
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022 39
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 40
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 2 (TOP-DOWN-BASED ESTIMATION), 2022 41
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 41
FIGURE 7 INSIGHTS ON CELL ISOLATION MARKET FROM PRIMARY EXPERTS 41
2.3 MARKET GROWTH RATE PROJECTIONS 43
FIGURE 8 CELL ISOLATION MARKET: CAGR PROJECTIONS, 2023–2028 43
FIGURE 9 CELL ISOLATION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS 44
2.4 DATA TRIANGULATION 45
FIGURE 10 DATA TRIANGULATION METHODOLOGY 45
2.5 RESEARCH ASSUMPTIONS 46
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT 46
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 46
3 EXECUTIVE SUMMARY 48
FIGURE 11 CELL ISOLATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 48
FIGURE 12 CELL ISOLATION MARKET, BY CELL TYPE, 2023 VS. 2028 (USD MILLION) 49
FIGURE 13 CELL ISOLATION MARKET, BY CELL SOURCE, 2023 VS. 2028 (USD MILLION) 49
FIGURE 14 CELL ISOLATION MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION) 50
FIGURE 15 CELL ISOLATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 50
FIGURE 16 CELL ISOLATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 51
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF CELL ISOLATION MARKET 52
4 PREMIUM INSIGHTS 53
4.1 CELL ISOLATION MARKET OVERVIEW 53
FIGURE 18 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE GROWTH 53
4.2 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT AND COUNTRY (2022) 54
FIGURE 19 CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 54
4.3 CELL ISOLATION MARKET SHARE, BY APPLICATION, 2023 VS. 2028 54
FIGURE 20 BIOMOLECULE ISOLATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 54
4.4 CELL ISOLATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 22 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
TABLE 2 CELL ISOLATION MARKET: IMPACT ANALYSIS 57
5.2.1 DRIVERS 57
5.2.1.1 Increasing government funding for cell-based research 57
TABLE 3 NIH FUNDING FOR CELL-BASED RESEARCH, 2019–2022 (USD MILLION) 57
5.2.1.2 Increasing number of patients suffering from cancer and infectious diseases 58
TABLE 4 INCIDENCE OF CANCER, BY REGION, 2020 58
TABLE 5 IMPORTANT STATISTICS ON INFECTIOUS DISEASES 59
5.2.1.3 Technological advancements 59
5.2.1.4 Growing focus on personalized medicine 59
TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015–2021 60
5.2.2 RESTRAINTS 60
5.2.2.1 Ethical & safety issues related to embryonic stem cell isolation 60
5.2.2.2 High cost of cell-based research 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 Growth opportunities in emerging markets 61
5.2.4 CHALLENGES 61
5.2.4.1 Obstacles to developing cell therapies 61
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 62
FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS 62
5.4 PRICING ANALYSIS 62
TABLE 7 PRICE OF KEY CELL ISOLATION PRODUCTS OF KEY COMPANIES (2022) 62
5.5 VALUE CHAIN ANALYSIS 63
FIGURE 24 CELL ISOLATION MARKET: VALUE CHAIN ANALYSIS 64
5.6 ECOSYSTEM ANALYSIS 64
TABLE 8 CELL ISOLATION MARKET ECOSYSTEM 65
5.7 REGULATORY ANALYSIS 65
5.8 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 9 CELL ISOLATION/ CELL SEPARATION MARKET: PORTER’S FIVE FORCES ANALYSIS 66
5.8.1 THREAT FROM NEW ENTRANTS 66
5.8.2 THREAT FROM SUBSTITUTES 67
5.8.3 BARGAINING POWER OF SUPPLIERS 67
5.8.4 BARGAINING POWER OF BUYERS 67
5.8.5 DEGREE OF COMPETITION 67
5.9 KEY CONFERENCES & EVENTS IN 2023–2024 67
TABLE 10 CELL ISOLATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS 67
5.10 TECHNOLOGY ANALYSIS 68
5.10.1 MICROFLUIDICS 68
5.10.2 MAGNETIC CELL ISOLATION 68
5.10.3 FLUORESCENCE-ACTIVATED CELL SORTING (FACS) 68
5.10.4 ACOUSTIC CELL ISOLATION 69
5.10.5 ACOUSTO-FLUIDIC CELL ISOLATION 69
5.11 KEY STAKEHOLDERS & BUYING CRITERIA 69
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL ISOLATION PRODUCTS 69
FIGURE 26 KEY BUYING CRITERIA FOR CELL ISOLATION PRODUCTS 70
5.12 TRADE ANALYSIS 71
TABLE 11 EXPORT DATA (TOP 10 COUNTRIES) 71
TABLE 12 IMPORT DATA (TOP 10 COUNTRIES) 71
5.13 PATENT ANALYSIS 72
FIGURE 27 PATENT APPLICATIONS RELATED TO CELL ISOLATION, JANUARY 2012–MARCH 2023 72
TABLE 13 LIST OF PATENTS IN CELL ISOLATION MARKET 72
6 CELL ISOLATION MARKET, BY PRODUCT 73
6.1 INTRODUCTION 74
TABLE 14 CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 74
6.2 CONSUMABLES 74
TABLE 15 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 75
TABLE 16 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 17 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 18 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 19 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 20 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 76
6.2.1 REAGENTS, KITS, MEDIA, AND SERA 77
6.2.1.1 Disposable nature of reagents and assay kits to drive consistent usage and frequent purchases 77
TABLE 21 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 22 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 23 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 24 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 25 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION) 78
6.2.2 BEADS 79
TABLE 26 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2021–2028 (USD MILLION) 79
TABLE 27 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 28 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 29 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 30 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 31 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 81
6.2.2.1 Magnetic beads 81
6.2.2.1.1 Growing demand for magnetic beads in T-cell and stem cell isolation to drive growth 81
TABLE 32 CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 33 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 34 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 35 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 36 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 83
6.2.2.2 Fluorescent beads 83
6.2.2.2.1 Advantages of fluorescent beads to boost adoption 83
TABLE 37 CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 38 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 39 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 40 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 41 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION) 85
6.2.3 DISPOSABLES 85
6.2.3.1 Growing government investments in research to boost growth 85
TABLE 42 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 43 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 44 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 45 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 46 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION) 87
6.3 INSTRUMENTS 87
TABLE 47 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 48 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 49 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 50 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 51 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 52 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
6.3.1 CENTRIFUGES 89
6.3.1.1 Growing use of centrifuges in pharma-biotech industry to boost market 89
TABLE 53 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 54 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 55 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 56 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 57 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION) 91
6.3.2 CELL SORTERS 91
6.3.2.1 Launch of innovative and cost-effective cell sorters to support market 91
TABLE 58 CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION) 92
TABLE 59 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 60 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 61 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 62 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS 93
6.3.3.1 Growing focus on personalized medicine to drive segmental growth 93
TABLE 63 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 64 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 65 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 66 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 67 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 95
6.3.4 FILTRATION SYSTEMS 95
6.3.4.1 Increasing research activities in cell biology to boost market 95
TABLE 68 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2021–2028 (USD MILLION) 96
TABLE 69 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 70 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 71 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 72 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION) 97
7 CELL ISOLATION MARKET, BY CELL TYPE 98
7.1 INTRODUCTION 99
TABLE 73 CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 99
7.2 HUMAN CELLS 99
TABLE 74 CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 75 CELL ISOLATION MARKET FOR HUMAN CELLS, BY REGION, 2021–2028 (USD MILLION) 100
TABLE 76 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 77 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 78 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 79 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 101
7.2.1 DIFFERENTIATED CELLS 102
7.2.1.1 Growing investments by market players to develop new and innovative products to support growth 102
TABLE 80 CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2021–2028 (USD MILLION) 102
TABLE 81 NORTH AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 82 EUROPE: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 83 ASIA PACIFIC: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 84 LATIN AMERICA: CELL ISOLATION MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 104
7.2.2 STEM CELLS 104
7.2.2.1 Rising government initiatives focused on supporting stem cell research to drive market 104
TABLE 85 CELL ISOLATION MARKET FOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 86 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 87 EUROPE: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 88 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 89 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 106
7.3 ANIMAL CELLS 106
7.3.1 INCREASING INVESTMENTS IN BIOPHARMACEUTICAL R&D FOR VACCINE AND DRUG DEVELOPMENT TO BOOST MARKET 106
TABLE 90 CELL ISOLATION MARKET FOR ANIMAL CELLS, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 91 NORTH AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 92 EUROPE: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 93 ASIA PACIFIC: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 94 LATIN AMERICA: CELL ISOLATION MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 108
8 CELL ISOLATION MARKET, BY CELL SOURCE 109
8.1 INTRODUCTION 110
TABLE 95 CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 110
8.2 BONE MARROW 110
8.2.1 GROWING NUMBER OF COMMERCIALIZED BONE MARROW-DERIVED STEM CELLS TO DRIVE MARKET 110
TABLE 96 CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 97 NORTH AMERICA: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 98 EUROPE: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 99 ASIA PACIFIC: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 100 LATIN AMERICA: CELL ISOLATION MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 112
8.3 ADIPOSE TISSUE 112
8.3.1 ABILITY OF ADIPOSE STEM/STROMAL CELLS TO GENERATE VARIETY OF OTHER CELL TYPES TO DRIVE DEMAND 112
TABLE 101 CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 102 NORTH AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 103 EUROPE: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 104 ASIA PACIFIC: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 105 LATIN AMERICA: CELL ISOLATION MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 114
8.4 CORD BLOOD/EMBRYONIC STEM CELLS 114
8.4.1 HIGH THERAPEUTIC POTENCY OF CORD BLOOD/EMBRYONIC STEM CELLS TO SUPPORT MARKET 114
TABLE 106 CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 107 NORTH AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 108 EUROPE: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 109 ASIA PACIFIC: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 110 LATIN AMERICA: CELL ISOLATION MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION) 116
8.5 OTHER CELL SOURCES 116
TABLE 111 CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 112 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 113 EUROPE: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 114 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 115 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION) 118
9 CELL ISOLATION MARKET, BY TECHNIQUE 119
9.1 INTRODUCTION 120
TABLE 116 CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 120
9.2 CENTRIFUGATION-BASED CELL ISOLATION 120
9.2.1 COST-EFFECTIVENESS OF TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS TO DRIVE MARKET 120
TABLE 117 CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 118 NORTH AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 119 EUROPE: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 120 ASIA PACIFIC: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 121 LATIN AMERICA: CENTRIFUGATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.3 SURFACE MARKER-BASED CELL ISOLATION 122
9.3.1 WIDE USAGE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES TO SUPPORT GROWTH 122
TABLE 122 SURFACE MARKER-BASED CELL ISOLATION MARKET, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 123 NORTH AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 124 EUROPE: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 125 ASIA PACIFIC: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 126 LATIN AMERICA: SURFACE MARKER-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
9.4 FILTRATION-BASED CELL ISOLATION 125
9.4.1 LOW COST OF FILTRATION TECHNIQUE TO BOOST ADOPTION 125
TABLE 127 FILTRATION-BASED CELL ISOLATION MARKET, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 128 NORTH AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 129 EUROPE: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 130 ASIA PACIFIC: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 131 LATIN AMERICA: FILTRATION-BASED CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
10 CELL ISOLATION MARKET, BY APPLICATION 127
10.1 INTRODUCTION 128
TABLE 132 CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 128
10.2 BIOMOLECULE ISOLATION 128
10.2.1 BIOMOLECULE ISOLATION SEGMENT TO DOMINATE CELL ISOLATION MARKET DURING FORECAST PERIOD 128
TABLE 133 CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 134 NORTH AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 135 EUROPE: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 136 ASIA PACIFIC: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 137 LATIN AMERICA: CELL ISOLATION MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 130
10.3 CANCER RESEARCH 130
10.3.1 HIGH DISEASE INCIDENCE TO FUEL DEMAND FOR ADVANCED TREATMENTS 130
TABLE 138 CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 139 NORTH AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 140 EUROPE: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 141 ASIA PACIFIC: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 142 LATIN AMERICA: CELL ISOLATION MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 132
10.4 STEM CELL RESEARCH 133
10.4.1 INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH 133
TABLE 143 CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 133
TABLE 144 NORTH AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 145 EUROPE: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 146 ASIA PACIFIC: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 147 LATIN AMERICA: CELL ISOLATION MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 135
10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE 135
10.5.1 GROWING REGENERATIVE MEDICINE INITIATIVES TO SUPPORT MARKET 135
TABLE 148 CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 136
TABLE 149 NORTH AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 150 EUROPE: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 136
TABLE 151 ASIA PACIFIC: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 152 LATIN AMERICA: CELL ISOLATION MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 137
10.6 IN VITRO DIAGNOSTICS 137
10.6.1 RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS 137
TABLE 153 CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 138
TABLE 154 NORTH AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 155 EUROPE: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 156 ASIA PACIFIC: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 139
TABLE 157 LATIN AMERICA: CELL ISOLATION MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 139
10.7 OTHER APPLICATIONS 140
TABLE 158 CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 140
TABLE 159 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 160 EUROPE: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 161 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 162 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 141
11 CELL ISOLATION MARKET, BY END USER 142
11.1 INTRODUCTION 143
TABLE 163 CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 143
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 143
11.2.1 FAVORABLE R&D INVESTMENTS TO BOOST MARKET GROWTH 143
TABLE 164 CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 144
TABLE 165 NORTH AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 166 EUROPE: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 144
TABLE 167 ASIA PACIFIC: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 168 LATIN AMERICA: CELL ISOLATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 145
11.3 ACADEMIC & RESEARCH INSTITUTES 145
11.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH 145
TABLE 169 CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 146
TABLE 170 NORTH AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 146
TABLE 171 EUROPE: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 172 ASIA PACIFIC: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 173 LATIN AMERICA: CELL ISOLATION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 147
11.4 HOSPITALS & DIAGNOSTIC LABORATORIES 148
11.4.1 INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES TO CONTRIBUTE TO MARKET GROWTH 148
TABLE 174 CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 148
TABLE 175 NORTH AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 176 EUROPE: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 177 ASIA PACIFIC: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 149
TABLE 178 LATIN AMERICA: CELL ISOLATION MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 150
11.5 OTHER END USERS 150
TABLE 179 CELL ISOLATION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 150
TABLE 180 NORTH AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 181 EUROPE: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 182 ASIA PACIFIC: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 151
TABLE 183 LATIN AMERICA: CELL ISOLATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 151
12 CELL ISOLATION MARKET, BY REGION 152
12.1 INTRODUCTION 153
TABLE 184 CELL ISOLATION MARKET, BY REGION, 2021–2028 (USD MILLION) 153
12.2 NORTH AMERICA 153
FIGURE 28 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT 154
TABLE 185 NORTH AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 154
TABLE 186 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 187 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 188 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 155
TABLE 189 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 156
TABLE 190 NORTH AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 191 NORTH AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 156
TABLE 192 NORTH AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 157
TABLE 193 NORTH AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 194 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 158
12.2.1 US 158
12.2.1.1 US to dominate North American cell isolation market during forecast period 158
TABLE 195 US: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 159
TABLE 196 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 197 US: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 198 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 199 US: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 160
TABLE 200 US: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 201 US: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 161
TABLE 202 US: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 161
TABLE 203 US: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 161
TABLE 204 US: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 162
12.2.2 CANADA 162
12.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada 162
TABLE 205 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 163
TABLE 206 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 207 CANADA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 208 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 209 CANADA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 164
TABLE 210 CANADA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 211 CANADA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 165
TABLE 212 CANADA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 165
TABLE 213 CANADA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 214 CANADA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 166
12.2.3 NORTH AMERICA: RECESSION IMPACT 166
12.3 EUROPE 167
TABLE 215 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 216 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 167
TABLE 217 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 218 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 219 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 168
TABLE 220 EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 169
TABLE 221 EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 222 EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 169
TABLE 223 EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 170
TABLE 224 EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 225 EUROPE: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 170
12.3.1 GERMANY 171

12.3.1.1 Germany to be fastest-growing market for cell isolation in Europe 171
TABLE 226 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 171
TABLE 227 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 171
TABLE 228 GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 229 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 230 GERMANY: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 172
TABLE 231 GERMANY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 232 GERMANY: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 173
TABLE 233 GERMANY: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 173
TABLE 234 GERMANY: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 174
TABLE 235 GERMANY: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 174
12.3.2 UK 174
12.3.2.1 Government investments in stem cell research to drive market for cell isolation in UK 174
TABLE 236 UK: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 175
TABLE 237 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 238 UK: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 239 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 240 UK: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 176
TABLE 241 UK: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 242 UK: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 177
TABLE 243 UK: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 177
TABLE 244 UK: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 245 UK: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 178
12.3.3 FRANCE 178
12.3.3.1 Increasing prevalence of various chronic and infectious diseases to drive market growth 178
TABLE 246 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 247 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 248 FRANCE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 249 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 250 FRANCE: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 180
TABLE 251 FRANCE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 252 FRANCE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 180
TABLE 253 FRANCE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 181
TABLE 254 FRANCE: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 181
TABLE 255 FRANCE: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 181
12.3.4 ITALY 182
12.3.4.1 Increasing number of cell biology seminars and conferences to fuel adoption of cell isolation products 182
TABLE 256 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 182
TABLE 257 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 182
TABLE 258 ITALY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 259 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 260 ITALY: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 183
TABLE 261 ITALY: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 262 ITALY: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 184
TABLE 263 ITALY: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 184
TABLE 264 ITALY: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 185
TABLE 265 ITALY: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 185
12.3.5 SPAIN 185
12.3.5.1 Increasing funding from private and public organizations to aid growth 185
TABLE 266 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 186
TABLE 267 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 268 SPAIN: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 269 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 270 SPAIN: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 187
TABLE 271 SPAIN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 187
TABLE 272 SPAIN: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 188
TABLE 273 SPAIN: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 188
TABLE 274 SPAIN: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 188
TABLE 275 SPAIN: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 189
12.3.6 REST OF EUROPE 189
TABLE 276 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 189
TABLE 277 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 278 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 279 REST OF EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 190
TABLE 280 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 191
TABLE 281 REST OF EUROPE: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 191
TABLE 282 REST OF EUROPE: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 191
TABLE 283 REST OF EUROPE: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 192
TABLE 284 REST OF EUROPE: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 192
TABLE 285 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 192
12.3.7 EUROPE: RECESSION IMPACT 193
12.4 ASIA PACIFIC 193
FIGURE 29 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT 194
TABLE 286 ASIA PACIFIC: CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 194
TABLE 287 ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 195
TABLE 288 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 289 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 290 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 291 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 196
TABLE 292 ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 293 ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 197
TABLE 294 ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 197
TABLE 295 ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 197
TABLE 296 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 198
12.4.1 CHINA 198
12.4.1.1 Growing cell therapy-based research in China to boost market 198
TABLE 297 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 198
TABLE 298 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 299 CHINA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 300 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 301 CHINA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 200
TABLE 302 CHINA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 200
TABLE 303 CHINA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 200
TABLE 304 CHINA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 201
TABLE 305 CHINA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 201
TABLE 306 CHINA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 201
12.4.2 JAPAN 202
12.4.2.1 Increasing geriatric population and subsequent rise in prevalence of chronic diseases to drive market 202
TABLE 307 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 202
TABLE 308 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 309 JAPAN: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 310 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 311 JAPAN: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 203
TABLE 312 JAPAN: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 313 JAPAN: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 204
TABLE 314 JAPAN: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 204
TABLE 315 JAPAN: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 204
TABLE 316 JAPAN: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 205
12.4.3 INDIA 205
12.4.3.1 Rising incidence of chronic and infectious diseases to drive demand for cell isolation products 205
TABLE 317 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 205
TABLE 318 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 319 INDIA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 320 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 206
TABLE 321 INDIA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 207
TABLE 322 INDIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 207
TABLE 323 INDIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 207
TABLE 324 INDIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 208
TABLE 325 INDIA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 208
TABLE 326 INDIA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 208
12.4.4 AUSTRALIA 209
12.4.4.1 Rising stem cell research to drive demand for cell isolation products 209
TABLE 327 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 209
TABLE 328 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 209
TABLE 329 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 330 AUSTRALIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 210
TABLE 331 AUSTRALIA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 210
TABLE 332 AUSTRALIA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 211
TABLE 333 AUSTRALIA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 211
TABLE 334 AUSTRALIA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 211
TABLE 335 AUSTRALIA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 212
TABLE 336 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 212
12.4.5 REST OF ASIA PACIFIC 213
TABLE 337 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213
TABLE 338 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 213
TABLE 339 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 340 REST OF ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 341 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 214
TABLE 342 REST OF ASIA PACIFIC: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 343 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 215
TABLE 344 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 215
TABLE 345 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 216
TABLE 346 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 216
12.4.6 ASIA PACIFIC: RECESSION IMPACT 216
12.5 LATIN AMERICA 217
TABLE 347 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 217
TABLE 348 LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 218
TABLE 349 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 350 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 218
TABLE 351 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 352 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 219
TABLE 353 LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 219
TABLE 354 LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 220
TABLE 355 LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 220
TABLE 356 LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 220
TABLE 357 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 221
12.5.1 BRAZIL 221
12.5.1.1 Expansion of leading market players in country to drive market growth 221
TABLE 358 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 221
TABLE 359 BRAZIL: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 360 BRAZIL: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 361 BRAZIL: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 362 BRAZIL: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 223
TABLE 363 BRAZIL: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 364 BRAZIL CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 223
TABLE 365 BRAZIL: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 224
TABLE 366 BRAZIL: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 224
TABLE 367 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 224
12.5.2 REST OF LATIN AMERICA 225
TABLE 368 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 225
TABLE 369 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 370 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 225
TABLE 371 REST OF LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 372 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 226
TABLE 373 REST OF LATIN AMERICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 374 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 227
TABLE 375 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 227
TABLE 376 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 228
TABLE 377 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 228
12.5.3 LATIN AMERICA: RECESSION IMPACT 228
12.6 MIDDLE EAST & AFRICA 229
12.6.1 GROWING PHARMACEUTICAL INDUSTRY IN MEA TO DRIVE MARKET GROWTH 229
TABLE 378 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 229
TABLE 379 MIDDLE EAST & AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 380 MIDDLE EAST & AFRICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 381 MIDDLE EAST & AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 382 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY CELL TYPE, 2021–2028 (USD MILLION) 230
TABLE 383 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 384 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION) 231
TABLE 385 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION) 231
TABLE 386 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 232
TABLE 387 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION) 232
12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 233
13 COMPETITIVE LANDSCAPE 234
13.1 INTRODUCTION 234
13.2 STRATEGIES ADOPTED BY KEY PLAYERS 234
FIGURE 30 CELL ISOLATION MARKET: STRATEGIES ADOPTED 234
13.3 MARKET SHARE ANALYSIS 235
FIGURE 31 CELL ISOLATION MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022) 235
TABLE 388 CELL ISOLATION MARKET: DEGREE OF COMPETITION 236
13.4 REVENUE ANALYSIS 237
FIGURE 32 CELL ISOLATION MARKET: REVENUE ANALYSIS, BY KEY PLAYER (2020–2022) 237
13.5 COMPANY EVALUATION MATRIX 238
FIGURE 33 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX, 2022 238
13.5.1 STARS 239
13.5.2 EMERGING LEADERS 239
13.5.3 PERVASIVE PLAYERS 239
13.5.4 PARTICIPANTS 239
13.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 240
13.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES) 240
TABLE 389 END-USER, PRODUCT, AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 240
13.6.2 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES) 241
TABLE 390 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS 241
13.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 242
TABLE 391 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 242
13.6.4 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES) 243
TABLE 392 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS 243
13.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 244
FIGURE 34 CELL ISOLATION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 244
13.7.1 PROGRESSIVE COMPANIES 244
13.7.2 STARTING BLOCKS 245
13.7.3 RESPONSIVE COMPANIES 245
13.7.4 DYNAMIC COMPANIES 245
13.7.5 COMPETITIVE BENCHMARKING OF START-UPS/SMES 245
TABLE 393 CELL ISOLATION MARKET: DETAILED LIST OF KEY START-UPS/SMES 245
TABLE 394 CELL ISOLATION MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 246
13.8 COMPETITIVE SCENARIO AND TRENDS 246
13.8.1 PRODUCT LAUNCHES 246
TABLE 395 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023 246
13.8.2 DEALS 247
TABLE 396 CELL ISOLATION MARKET: DEALS, JANUARY 2020–MAY 2023 247
13.8.3 OTHER DEVELOPMENTS 247
TABLE 397 CELL ISOLATION MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2023 247
14 COMPANY PROFILES 248
14.1 KEY PLAYERS 248
(Business Overview, Products offered, Recent Developments, MnM View)*
14.1.1 THERMO FISHER SCIENTIFIC, INC. 248
TABLE 398 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW 248
FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 249
14.1.2 BECTON, DICKINSON AND COMPANY (BD) 253
TABLE 399 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 253
FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 254
14.1.3 DANAHER CORPORATION 256
TABLE 400 DANAHER CORPORATION: COMPANY OVERVIEW 256
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 257
14.1.4 MERCK KGAA 259
TABLE 401 MERCK KGAA: COMPANY OVERVIEW 259
FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2022) 260
14.1.5 TERUMO CORPORATION 262
TABLE 402 TERUMO CORPORATION: COMPANY OVERVIEW 262
FIGURE 39 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 263
14.1.6 AGILENT TECHNOLOGIES, INC. 265
TABLE 403 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 265
FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 266
14.1.7 BIO-RAD LABORATORIES, INC. 268
TABLE 404 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 268
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 269
14.1.8 CORNING INCORPORATED 270
TABLE 405 CORNING INCORPORATED: COMPANY OVERVIEW 270
FIGURE 42 CORNING INCORPORATED: COMPANY SNAPSHOT (2022) 271
14.1.9 F. HOFFMANN-LA ROCHE LTD. 273
TABLE 406 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 273
FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022) 274
14.1.10 ALFA LAVAL 276
TABLE 407 ALFA LAVAL: COMPANY OVERVIEW 276
FIGURE 44 ALFA LAVAL: COMPANY SNAPSHOT (2022) 277
14.1.11 MILTENYI BIOTEC 279
TABLE 408 MILTENYI BIOTEC: COMPANY OVERVIEW 279
14.1.12 SARTORIUS AG 281
TABLE 409 SARTORIUS AG: COMPANY OVERVIEW 281
FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2022) 282
14.1.13 STEMCELL TECHNOLOGIES 284
TABLE 410 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW 284
14.1.14 AKADEUM LIFE SCIENCES 285
TABLE 411 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW 285
14.1.15 BIO-TECHNE 288
TABLE 412 BIO-TECHNE: COMPANY OVERVIEW 288
FIGURE 46 BIO-TECHNE: COMPANY SNAPSHOT (2022) 289
14.2 OTHER COMPANIES 291
14.2.1 TAKARA BIO INC. 291
14.2.2 QIAGEN 292
14.2.3 LONZA GROUP 292
14.2.4 PERKINELMER INC. (BIOLEGEND, INC.) 293
14.2.5 PROMEGA CORPORATION 294
14.2.6 PROTEINTECH GROUP, INC. 295
14.2.7 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG 295
14.2.8 INVENT BIOTECHNOLOGIES, INC. 296
14.2.9 MICAREO INC. 297
14.2.10 MAGBIO GENOMICS 298
*Details on Business Overview, Products offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX 299
15.1 DISCUSSION GUIDE 299
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 304
15.3 CUSTOMIZATION OPTIONS 306
15.4 RELATED REPORTS 306
15.5 AUTHOR DETAILS 307

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 細胞単離/細胞分離の世界市場予測（～2028年）：製品別、細胞別、細胞源別、技術別、用途別、エンドユーザー別(Cell Isolation/ Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の単一細胞解析市場（～2028年）：細胞タイプ別（ヒト、動物、微生物）、製品別（消耗品、装置）、手法別（フローサイトメトリー、NGS、顕微鏡、MS）、用途別（研究、医療）、エンドユーザー別（製薬、バイオテクノロジー、病院）
  • 幹細胞製造の世界市場予測（～2028）：製品別、用途別、エンドユーザー別、地域別
  • 生細胞イメージングの世界市場予測（～2028年）：製品別、用途別、技術別、エンドユーザー別
  • 世界の細胞ベースアッセイ市場（～2028年）：製品＆サービス別（試薬、アッセイキット、細胞株、マイクロプレート、プローブ＆ラベル、装置＆ソフトウェア）、用途別（創薬（毒性、薬物動態）、研究）、エンドユーザー別（CROS、製薬）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆